Clinical Trial: Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage

U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07724405) titled 'Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage' on July 14.

Brief Summary: Recurrent pregnancy loss (RPL), commonly referred to as recurrent miscarriage, affects approximately 1-2% of couples attempting to conceive. In nearly half of these cases, no definitive cause can be identified despite thorough clinical evaluation. A circumstance that is both distressing and disorienting for affected families, particularly in settings such as the United Arab Emirates (UAE), where childbearing carries significant personal and cultural weight.

One leading hypothesis is that the underlying problem may not lie...